Lawyers involved in the ongoing litigation over the drug Pradaxa have predicted that hundreds of lawsuits may eventually be filed by patients who were injured after taking the medication. Pradaxa is an anti-clotting drug that is prescribed to prevent stroke in patients with a common type of heart rhythm abnormality.
According to a warning by the Food and Drug Administration in December 2011, patients taking Pradaxa may face an increased risk of serious and potentially fatal bleeding compared with users of other medications. The agency had already received hundreds of reports of serious or fatal bleeding among Pradaxa users when the warning was announced, making it one of the most frequently reported drugs of 2011.
Unlike other anticlotting drugs such as warfarin, Pradaxa does not have an antidote or reversal agent that can induce clotting when excessive bleeding occurs. A study by the New England Journal of Medicine found that this lack of a reversal agent places Pradaxa users at significantly increased risk of side effects.
Patient who were treated with Pradaxa and suffered serious bleeding or other complications may be eligible to file a Pradaxa lawsuit. Although cases have already been filed, injured patients and their families can speak with a lawyer to find out if they are eligible to file suit.